XI’AN, CHINA--(Marketwire - August 24, 2009) - Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) (“Skystar” or the “Company”), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that Weibing Lu and Scott Scramer, Skystar’s Chairman & Chief Executive Officer and SkyStar’s director & U.S. spokesperson, will present at the Rodman & Renshaw Annual Global Investment Conference on Wednesday, September 9, 2009 at 2:00 p.m. Eastern time.
An audio and slide webcast of the live presentation will be available under the “Events and Presentations” page on the “Investor Relations” section of the Company’s website at http://www.ir-site.com/skystar/events.asp. An archived presentation will be available for 90 days.
About Skystar Bio-Pharmaceutical Company
Skystar is a China-based developer and distributor of veterinary healthcare and medical care products. Skystar has four product lines (veterinary medicines, micro-organisms, vaccines and feed additives) and over 170 products, with over 40 additional products in the developmental stage. Skystar has formed strategic sales distribution networks covering 29 provinces throughout China. For additional information, please visit http://www.skystarbio-pharmaceutical.com.
To be added to the Company’s email distribution for future news releases, please send your request to skystar@tpg-ir.com.
Contacts
The Piacente Group, Inc. (Investor Relations Counsel)
Brandi Floberg
(212) 481-2050
Email Contact
Skystar Bio-Pharmaceutical Company
Scott Cramer
Director - U.S. Representative
(407) 645-4433
Email Contact
